Second Manhood: A Multimedia Intervention for Male Sexual Problems after Cancer

第二个男子气概:癌症后男性性问题的多媒体干预

基本信息

  • 批准号:
    7800679
  • 负责人:
  • 金额:
    $ 17.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-28 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Sexual dysfunction is one of the most prevalent and persistent problems after cancer treatment. This Fast Track STTR will create and evaluate a multimedia educational and counseling tool to promote recovery of sexual satisfaction in men treated for cancer. Second Manhood: Recovering Your Sex Life after Cancer will be viewable over the internet, on a CD or DVD, or in printed form. It will help men understand how cancer treatments cause sexual problems, learn self-help strategies to improve sexual function, and optimize use of medical treatments. Partners will get advice, self-help exercises, and communication skills training to enhance their role in resolving sexual problems. For health care professionals, we are creating the Follow-Through System for Male Sexual Dysfunction (FT) to improve the quality and continuity of care. It will provide scheduled assessments, using Interactive Voice Recording (IVR) telephony. Scheduled symptom reports with rapid responses from the clinic staff should enhance the success of treatments for erectile dysfunction, preventing the common problem of men discontinuing a prescribed treatment, and then giving up. Phase I: Aim 1 is to use focus groups and interviews to tailor the text and video vignette components of Second Manhood (SM) to a diverse audience. We will assess 130 cancer survivors of varying ethnicity, sexual orientation, age, relationship status, and cancer history. Aim 2 is to use interviews with expert health care professionals (HCP's) to design and create the FT communication interface, pilot testing it in our Sexual Medicine Clinic at UT M. D. Anderson Cancer Center. A communication skills manual for HCP's will also be created. Phase II: We will recruit 360 men from this clinic and from a county hospital. All will be cancer survivors with no current evidence of disease, off active treatment, and seeking help for sexual dysfunction. Partners will be encouraged to participate. We will use adaptive randomization to assign men to one of three groups: Usual Care in the Sexual Medicine clinic (UC), UC + SM, or UC + SM + FT. Those receiving SM will be instructed to view and interact with the application and carry out behavioral homework. All men will complete a brief questionnaire on symptoms via the IVR at baseline, 12 weeks, and 24 weeks. The IVR will call FT group men and partners at 2, 4, 6, and 8 weeks to complete the Treatment Satisfaction Scale (TSS). FT group members will also be encouraged to initiate calls with questions or problems. A mid-level practitioner hired for the study will follow both SM groups. Men will complete additional brief questionnaires at baseline, 12 and 24 weeks assessing overall distress, marital satisfaction, quality of life, and a broad spectrum of sexual function. The hypothesis is that improvements in sexual function and satisfaction will be significantly greater at follow-up for the SM and SM + FT groups than the UC group, but the FT group will also have significantly better outcomes than the SM group. Partner participation and extent of website usage may be moderating variables. All participants will complete a program evaluation form at week 24. During Phase II an IVR-based Sexual Medicine Hotline will be piloted to facilitate both self- and HCP referrals to the Sexual Medicine Clinic. PUBLIC HEALTH RELEVANCE: According to the office of Cancer Survivorship, about 3,050,000 men in the United States are survivors of prostate, colorectal, or bladder cancer, which means at least 1,525,000 suffer from cancer-related sexual dysfunction. Research indicates that less than 20 percent of men end up satisfied with their recovery from sexual problems, even though 60 percent are distressed about them, and most try some type of medical help. Second Manhood provides education and counseling using multimedia technology to help men and their partners resolve cancer-related sexual dysfunction. A companion product, the Follow-Through System for Male Sexual Dysfunction uses Interactive Voice Recording (IVR) telephony to improve the consistency and quality of medical care for sexual problems.
描述(由申请人提供):性功能障碍是癌症治疗后最普遍和持久的问题之一。这个快速通道STTR将创建和评估一个多媒体教育和咨询工具,以促进癌症治疗男性性满意度的恢复。《第二个男人:癌症后的性生活恢复》将通过互联网、CD或DVD或印刷形式提供。它将帮助男性了解癌症治疗如何导致性问题,学习改善性功能的自助策略,并优化药物治疗的使用。合作伙伴将获得建议,自助练习和沟通技巧培训,以提高他们在解决性问题中的作用。对于卫生保健专业人员,我们正在创建男性性功能障碍后续系统(FT),以提高护理质量和连续性。它将利用交互式录音电话提供预定的评估。定期的症状报告与诊所工作人员的快速反应应该提高勃起功能障碍治疗的成功率,防止男性停止处方治疗的常见问题,然后放弃。第一阶段:目标1是利用焦点小组和访谈,为不同的观众量身定制第二个男子汉(SM)的文本和视频小插曲组件。我们将评估130名不同种族、性取向、年龄、关系状况和癌症史的癌症幸存者。目标2是使用与专家医疗保健专业人员(HCP)的访谈来设计和创建FT沟通界面,并在UT M的性医学诊所进行试点测试。D.安德森癌症中心。还将为HCP编写一本沟通技能手册。第二阶段:我们将从这个诊所和一个县医院招募360名男子。所有人都将是癌症幸存者,目前没有疾病证据,没有积极治疗,并寻求性功能障碍的帮助。将鼓励合作伙伴参与。我们将使用适应性随机化将男性分配到三组之一:性医学诊所(UC)的生殖保健,UC + SM或UC + SM + FT。接收SM的人将被指示查看应用程序并与应用程序进行交互,并进行行为作业。所有男性将在基线、12周和24周时通过IVR完成一份关于症状的简短问卷。IVR将在第2、4、6和8周时致电FT组男性和伴侣,以完成治疗满意度量表(TSS)。FT小组成员也将被鼓励主动提出问题或问题。为这项研究聘请的中级从业人员将跟踪两个SM组。男性将在基线、第12周和第24周完成额外的简短问卷,评估整体痛苦、婚姻满意度、生活质量和广泛的性功能。假设SM和SM + FT组在随访时性功能和满意度的改善显著大于UC组,但FT组的结局也显著优于SM组。合作伙伴的参与和网站的使用程度可能是调节变量。所有参与者将在第24周完成计划评估表。在第二阶段,将试行基于IVR的性医学热线,以促进自我和HCP转诊到性医学诊所。 公共卫生相关性:根据癌症幸存者办公室的数据,美国约有3,050,000名男性是前列腺癌,结肠直肠癌或膀胱癌的幸存者,这意味着至少有1,525,000人患有癌症相关的性功能障碍。研究表明,不到20%的男性最终对他们从性问题中恢复感到满意,尽管60%的人对此感到痛苦,而且大多数人都尝试过某种形式的医疗帮助。Second Manhood利用多媒体技术提供教育和咨询,帮助男性及其伴侣解决与癌症有关的性功能障碍。作为配套产品,男性性功能障碍后续系统使用交互式语音记录(IVR)电话来提高性问题医疗护理的一致性和质量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PAUL MARTINETTI其他文献

PAUL MARTINETTI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PAUL MARTINETTI', 18)}}的其他基金

Second Manhood: A Multimedia Intervention for Male Sexual Problems after Cancer
第二个男子气概:癌症后男性性问题的多媒体干预
  • 批准号:
    8145579
  • 财政年份:
    2009
  • 资助金额:
    $ 17.93万
  • 项目类别:
Second Manhood: A Multimedia Intervention for Male Sexual Problems after Cancer
第二个男子气概:癌症后男性性问题的多媒体干预
  • 批准号:
    8928265
  • 财政年份:
    2009
  • 资助金额:
    $ 17.93万
  • 项目类别:
Second Manhood: A Multimedia Intervention for Male Sexual Problems after Cancer
第二个男子气概:癌症后男性性问题的多媒体干预
  • 批准号:
    8324715
  • 财政年份:
    2009
  • 资助金额:
    $ 17.93万
  • 项目类别:
Second Manhood: A Multimedia Intervention for Male Sexual Problems after Cancer
第二个男子气概:癌症后男性性问题的多媒体干预
  • 批准号:
    8135851
  • 财政年份:
    2009
  • 资助金额:
    $ 17.93万
  • 项目类别:
INTERACTIVE MEDIA ON BANKING SPERM BEFORE CANCER THERAPY
关于癌症治疗前储存精子的互动媒体
  • 批准号:
    6806041
  • 财政年份:
    2000
  • 资助金额:
    $ 17.93万
  • 项目类别:
INTERACTIVE MEDIA ON BANKING SPERM BEFORE CANCER THERAPY
关于癌症治疗前储存精子的互动媒体
  • 批准号:
    6793920
  • 财政年份:
    2000
  • 资助金额:
    $ 17.93万
  • 项目类别:
INTERACTIVE MEDIA ON BANKING SPERM BEFORE CANCER THERAPY
关于癌症治疗前储存精子的互动媒体
  • 批准号:
    6521855
  • 财政年份:
    2000
  • 资助金额:
    $ 17.93万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 17.93万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 17.93万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 17.93万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 17.93万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 17.93万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 17.93万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 17.93万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 17.93万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 17.93万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 17.93万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了